Xilinx Beats Analysts’ Q2 Estimates (XLNX)

Xilinx, Inc. (XLNX) announced its earnings results for its second quarter fiscal 2014 on Wednesday after the closing bell.

The company reported earnings of 58 cents per share, beating analysts’ estimates of 53 cents. Revenue was reported at $598.94 million, above the expected $588.28 million and a 3% increase from the prior quarter and up 10% from a year prior.

Top Medical Companies To Buy Right Now

Xilinx also reported that it expects sales to be up 2% to down 2% sequentially. Gross margin is expected to be approximately 69% for the December quarter fiscal 2014.

Xilinx shares traded 1.19% higher during Wednesday’s session. Year-to-date, the stock is up 25.02%.